Back to today’s briefing

Story perspectives

Breakthrough ALS Research Links LDLR to Motor Neuron Damage

3/24/2025

50 10

Summary

Story summary

At the 2025 MDA Conference, U.S. researchers unveiled groundbreaking findings linking low-density lipoprotein receptor (LDLR) signaling to neurodegeneration in sporadic amyotrophic lateral sclerosis (ALS). They revealed that the cholesterol transporter protein ApoB binds to LDLR, triggering motor neuron damage. Remarkably, blocking LDLR showed promise in halting these neurotoxic effects, underscoring its vital role in sporadic ALS.

1 of 1

Story summary

At the 2025 MDA Conference, U.S. researchers unveiled groundbreaking findings linking low-density lipoprotein receptor (LDLR) signaling to neurodegeneration in sporadic amyotrophic lateral sclerosis (ALS). They revealed that the cholesterol transporter protein ApoB binds to LDLR, triggering motor neuron damage. Remarkably, blocking LDLR showed promise in halting these neurotoxic effects, underscoring its vital role in sporadic ALS.